AU2003224274A1 - Human polypeptides having antibacterial activity - Google Patents

Human polypeptides having antibacterial activity

Info

Publication number
AU2003224274A1
AU2003224274A1 AU2003224274A AU2003224274A AU2003224274A1 AU 2003224274 A1 AU2003224274 A1 AU 2003224274A1 AU 2003224274 A AU2003224274 A AU 2003224274A AU 2003224274 A AU2003224274 A AU 2003224274A AU 2003224274 A1 AU2003224274 A1 AU 2003224274A1
Authority
AU
Australia
Prior art keywords
antibacterial activity
human polypeptides
polypeptides
human
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003224274A
Other versions
AU2003224274A8 (en
Inventor
Colin Bingle
Jeremy Craven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Publication of AU2003224274A8 publication Critical patent/AU2003224274A8/en
Publication of AU2003224274A1 publication Critical patent/AU2003224274A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742Bactericidal/Permeability-increasing protein [BPI]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2003224274A 2002-04-12 2003-04-11 Human polypeptides having antibacterial activity Abandoned AU2003224274A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0208925.8 2002-04-12
GBGB0208925.8A GB0208925D0 (en) 2002-04-12 2002-04-12 Polypeptide
PCT/GB2003/001583 WO2003087143A2 (en) 2002-04-12 2003-04-11 Human polypeptides having antibacterial activity

Publications (2)

Publication Number Publication Date
AU2003224274A8 AU2003224274A8 (en) 2003-10-27
AU2003224274A1 true AU2003224274A1 (en) 2003-10-27

Family

ID=9935101

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003224274A Abandoned AU2003224274A1 (en) 2002-04-12 2003-04-11 Human polypeptides having antibacterial activity

Country Status (3)

Country Link
AU (1) AU2003224274A1 (en)
GB (1) GB0208925D0 (en)
WO (1) WO2003087143A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005056045A1 (en) * 2003-12-04 2005-06-23 The University Of Iowa Research Foundation Methods and compositions related to plunc polypeptides
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5531898A (en) * 1996-12-23 1998-07-17 Human Genome Sciences, Inc. Human parotid secretory protein
EP1000084A4 (en) * 1997-07-08 2003-03-26 Human Genome Sciences Inc 123 human secreted proteins
EP1049770A1 (en) * 1998-01-02 2000-11-08 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU2001271589A1 (en) * 2000-06-30 2002-01-14 Zymogenetics Inc. Mammalian secreted proteins

Also Published As

Publication number Publication date
WO2003087143A3 (en) 2004-03-18
GB0208925D0 (en) 2002-05-29
AU2003224274A8 (en) 2003-10-27
WO2003087143A2 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
AU2003282779A1 (en) Antibacterial agents
AU2003300965A1 (en) Antibacterial agents
AU2003296475A1 (en) Phototherapy bandage
AU2003277362A1 (en) Titanium mattress member
IL166476A0 (en) Lincomycin derivatives possessing antibacterial activity
AU2003283257A1 (en) Scalp treatment
AU2003210877A1 (en) Hand covering
AU2003241291A1 (en) Vascularized human skin equivalent
AU2003282268A1 (en) Activity monitoring
AU2003280129A1 (en) Activity monitoring
AU2003253141A1 (en) Novel antibacterial agents
AU2002951144A0 (en) Aquatic activity garment
AU2003248153A1 (en) Honey-based skin care preparation
AU2003228198A1 (en) Av-fistula bandage
AU2003238959A1 (en) Skin care products
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003264406A1 (en) Drug or cosmetic
AU2003224345A1 (en) Antibacterial agents
AU2003288459A1 (en) Antibacterial agents
AU2003288248A1 (en) Dihalo-allyloxy-phenol derivatives having pesticidal activity
AU2003248263A1 (en) Cosmetic
AU2003298511A1 (en) Retroyclins: antiviral and antimicrobial peptides
AU2003217072A1 (en) Antibacterial agents
AU2003252075A1 (en) Human immunosuppressive protein
AU2003290684A1 (en) Novel anhydrolide derivatives having antibacterial activity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase